Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety, tolerability, and pharmacokinetics of
multiple doses of pregabalin in pediatric patients with partial onset seizures that are
incompletely controlled on their current medications.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.